Clincosm LogoSign in Get a demo

HIV Infections

Showing NaN - NaN of 406
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Worldwide (VH3739937, Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +18 more
Sep 22, 2023

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

HIV Trial in Miami (reSET, Standard of care)

Not yet recruiting
  • HIV Infections
  • reSET
  • Standard of care
  • Miami, Florida
    University of Miami
Jul 14, 2023

Stimulant Use and Methylation in HIV

Completed
  • HIV Infections
  • +2 more
    • Miami, Florida
      University of Miami
    Jun 14, 2023

    HIV Trial in Miami (Comprehensive Tele-harm Reduction, Off-site Linkage to HIV Prevention)

    Not yet recruiting
    • HIV Infections
    • Comprehensive Tele-harm Reduction
    • Off-site Linkage to HIV Prevention
    • Miami, Florida
      IDEA Syringe Services Program
    Jun 9, 2023

    HIV, Hiv, Sexually Transmitted Infections (Not HIV or Hepatitis) Trial in Miami (Para ti, para mi, para nosotros (P3), Waitlist

    Recruiting
    • HIV Infections
    • +5 more
    • Para ti, para mi, para nosotros (P3)
    • Waitlist Control Para ti, para mi, para nosotros (P3)
    • Miami, Florida
      Florida International University
    May 24, 2023

    HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

    Recruiting
    • HIV Infections
    • Oral Cabotegravir (CAB)
    • +4 more
    • La Jolla, California
    • +30 more
    Feb 2, 2023

    Hiv, HIV, Sexually Transmitted Infection Trial in Miami, Ann Arbor (Intervention LuvHub, Waitlist Control LuvHub)

    Recruiting
    • Hiv
    • +5 more
    • Intervention LuvHub
    • Waitlist Control LuvHub
    • Miami, Florida
    • +1 more
    Jan 23, 2023

    HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir Tablets
    • +4 more
    • Bakersfield, California
    • +116 more
    Jan 22, 2023

    HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • +2 more
    • Los Angeles, California
    • +13 more
    Dec 19, 2022

    Consent for Use of Stored Patient Specimens for Future Testing

    Recruiting
    • HIV Infections
      • Los Angeles, California
      • +62 more
      Dec 7, 2022

      HIV Trial in United States (APRETUDE, Cabotegravir OLI)

      Recruiting
      • HIV Infections
      • Los Angeles, California
      • +16 more
      Oct 24, 2022

      HIV, Sexually Transmitted Diseases Trial in San Francisco, Washington, Miami (PrEPmate, Dot Diary)

      Recruiting
      • HIV Infections
      • Sexually Transmitted Diseases
      • PrEPmate
      • Dot Diary
      • San Francisco, California
      • +3 more
      Sep 27, 2022

      Alcohol Drinking, Chronic Inflammation, Neurocognitive Dysfunction Trial in Miami (Contingency Management (CM))

      Active, not recruiting
      • Alcohol Drinking
      • +4 more
      • Contingency Management (CM)
      • Miami, Florida
        University of Miami
      Sep 26, 2022

      HIV Trial in Miami, Detroit, Philadelphia (Clinic-based Delivery, Remote Delivery, Multi-modal Delivery)

      Completed
      • HIV Infections
      • Clinic-based Delivery
      • +2 more
      • Miami, Florida
      • +2 more
      Sep 6, 2022

      IV Drug Usage, HIV, Hepatitis C Trial in Miami, Tampa (Tele-Harm Reduction, off-site linkage)

      Not yet recruiting
      • IV Drug Usage
      • +2 more
      • Tele-Harm Reduction
      • off-site linkage
      • Miami, Florida
      • +1 more
      Aug 9, 2022

      Antiretroviral Drugs and Related Drugs During and After

      Completed
      Has Results
      • HIV Infections
      • Birmingham, Alabama
      • +61 more
      Jun 28, 2022

      HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))

      Completed
      Has Results
      • HIV Infections
      • DTG + 3TC
      • TAF based regimen (TBR)
      • Phoenix, Arizona
      • +132 more
      Jun 27, 2022

      HIV Trial in Worldwide (GSK3640254, Dolutegravir, Lamivudine capsules)

      Active, not recruiting
      • HIV Infections
      • Bakersfield, California
      • +75 more
      Jul 1, 2022

      Harm Reduction, HIV, Drug Use Trial in Miami (Biktarvy 50Mg-200Mg-25Mg Tablet, HIV care)

      Recruiting
      • Harm Reduction
      • +2 more
      • Biktarvy 50Mg-200Mg-25Mg Tablet
      • HIV care
      • Miami, Florida
        University of Miami
      May 4, 2022

      Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)

      Active, not recruiting
      Has Results
      • Infection, Human Immunodeficiency Virus
      • HIV Infections
      • Dolutegravir/abacavir/lamivudine FDC
      • +3 more
      • Phoenix, Arizona
      • +88 more
      Feb 8, 2022

      HIV Trial in Puerto Rico, United States (Atazanavir, Darunavir, Efavirenz)

      Completed
      • HIV Infections
      • Alhambra, California
      • +22 more
      Nov 3, 2021

      HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) monovalent vaccine)

      Completed
      Has Results
      • HIV Infections
      • H1N1 Influenza Virus
      • Influenza A (H1N1) monovalent vaccine
      • Alhambra, California
      • +30 more
      Nov 3, 2021

      HIV, H1N1 Influenza Virus Trial in Puerto Rico, United States (Influenza A (H1N1) 2009 monovalent vaccine)

      Completed
      Has Results
      • HIV Infections
      • H1N1 Influenza Virus
      • Influenza A (H1N1) 2009 monovalent vaccine
      • Birmingham, Alabama
      • +36 more
      Nov 3, 2021

      HIV Trial in San Francisco, Washington, Miami (FTC 200 mg/TDF 300 mg fixed-dose combination tablet)

      Completed
      Has Results
      • HIV Infections
      • FTC 200 mg/TDF 300 mg fixed-dose combination tablet
      • San Francisco, California
      • +2 more
      Nov 3, 2021